Go to the list of all blogs
published in Blogs
Jul 14, 2026
Gartner (IT) Down 46% YTD: Assessing the Research Firm's Position and Path Forward

Gartner (IT) Down 46% YTD: Assessing the Research Firm's Position and Path Forward

Key Takeaways

  • Gartner shares closed at $141.31 on July 13, 2026, reflecting a modest 4.6% decline over the trailing 30 days and a significantly steeper 46% year-to-date drop.
  • The company's Q1 2026 earnings surpassed EPS estimates ($3.32 vs. $2.99 consensus), yet revenue of $1.49 billion missed expectations and contracted 1.5% year-over-year.
  • Analyst sentiment remains cautious with a consensus Hold rating and an average price target of approximately $173, though recent target reductions from Wells Fargo, Barclays, and UBS signal near-term headwinds.
  • Gartner continues to command a dominant position in AI and technology research, with its Magic Quadrant reports remaining industry benchmarks for enterprise decision-makers worldwide.
  • Institutional investors hold 91.51% of outstanding shares, though several notable firms trimmed positions in the first quarter, reflecting mixed conviction levels.

Where Gartner Stands in Today’s Market

Gartner, Inc. (NYSE: IT) has navigated a challenging 2026, with the stock sliding from $252.14 at the start of the year to approximately $141 by mid-July. The shares have traded in a wide 52-week range between $124.25 and $375.84, underscoring the magnitude of the drawdown. The stock currently trades well below both its 50-day moving average of roughly $147 and its 200-day moving average near $170. With a price-to-earnings ratio of approximately 14 and a market capitalization near $9.5 billion, Gartner's valuation has compressed meaningfully relative to historical levels, prompting debate among analysts about whether the selloff represents a structural re-rating or a potential value opportunity. From what I see, this compression invites closer scrutiny of the underlying business fundamentals.

Understanding Gartner’s Core Business and Competitive Edge

Headquartered in Stamford, Connecticut, Gartner is a global research and advisory firm that equips business leaders across IT, finance, HR, customer service, and other functions with data-driven insights and strategic guidance. Founded in 1979, the company operates through three primary segments: Research, Conferences, and Consulting. Its proprietary Magic Quadrant reports and Hype Cycles are widely regarded as authoritative frameworks used by technology buyers and vendors to evaluate products, services, and market trends. Gartner's subscription-based research model generates recurring revenue streams, while its globally recognized conferences attract senior executives from Fortune 500 companies. The firm's entrenched brand, deep institutional relationships, and vast repository of proprietary data create meaningful competitive moats that have historically supported pricing power and client retention. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Key Events Shaping Recent Performance

Several factors have shaped Gartner's stock performance in recent weeks. In late June, Wells Fargo & Company reiterated an Underweight rating and slashed its price target to $120, citing concerns about decelerating contract value growth and headwinds in enterprise technology spending. Around the same time, Weiss Ratings downgraded the stock further into sell territory. These moves followed earlier target reductions from Barclays ($150, Equal Weight) and UBS ($164, Neutral). On a more constructive note, Gartner was added to the Russell 2500 Index and Russell 2500 Growth Benchmark in the latest reconstitution, though it simultaneously exited certain Russell 1000 defensive indices. The company's research arm continues to generate significant visibility in the AI sector, with its Magic Quadrant reports for Conversational AI Platforms and Cloud AI Infrastructure remaining highly influential. Additionally, Gartner executed $5.35 billion in share repurchases during the first quarter, signaling management's confidence in long-term intrinsic value despite near-term revenue softness.

2026 Outlook and What Investors Should Watch

Looking ahead, Gartner's trajectory in 2026 hinges on several interconnected factors. The company's Q2 earnings report, expected in early August, will provide critical updates on contract value growth across its Global Technology Sales and Global Business Sales segments. Investors should monitor whether the modest 0.4% FX-neutral growth in technology contract value recorded in Q1 accelerates or further decelerates. Macroeconomic uncertainty, including enterprise budget scrutiny and potential shifts in IT spending priorities, remains a key risk. On the positive side, the accelerating enterprise adoption of AI, cybersecurity, and digital transformation initiatives could drive demand for Gartner's research and advisory services. The company's strong free cash flow generation and aggressive share buyback program may provide valuation support. Analyst consensus points to full-year EPS of approximately $13.65, against management's guidance of at least $13.25. The wide gap between the current share price and the consensus analyst target of roughly $173 indicates that the market remains divided on whether Gartner's recent challenges are temporary or indicative of a more prolonged growth deceleration. One thing that stands out is how these dynamics could play out in the coming quarters.

Exploring Tickeron’s Trending AI Robots

For traders seeking an automated, data-driven approach to navigating markets, Tickeron's Trending AI Robots page offers a curated selection of top-performing AI trading bots. Tickeron's platform hosts hundreds of AI-powered trading bots spanning thousands of tickers across diverse strategies and timeframes. Only the most consistently relevant and high-performing bots earn placement in the Trending section, which serves as a streamlined discovery tool for users evaluating algorithmic trading strategies. Each bot is designed with distinct parameters, risk profiles, and performance metrics, enabling traders to align automated strategies with their individual objectives. Explore the Trending AI Robots page to see which strategies are currently gaining traction.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: IT

IT sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for IT moved above the 200-day moving average on September 23, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 33 of 56 cases where IT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 59%.

The Momentum Indicator moved above the 0 level on October 05, 2026. You may want to consider a long position or call options on IT as a result. In 56 of 75 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.

Following a +3.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where IT advanced for three days, in 216 of 341 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

IT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 102 of 192 cases where IT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 53%.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for IT turned negative on October 02, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 27 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 59%.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 13 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 34 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. IT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 93 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: IT's P/B Ratio (161.290) is very high in comparison to the industry average of (7.462). P/E Ratio (16.702) is within average values for comparable stocks, (67.645). Projected Growth (PEG Ratio) (0.737) is also within normal values, averaging (2.284). Dividend Yield (0.000) settles around the average of (0.010) among similar stocks. P/S Ratio (2.103) is also within normal values, averaging (141.758).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

Notable companies

The most notable companies in this group are International Business Machines Corp (NYSE:IBM), Accenture PLC (NYSE:ACN), Unisys Corp (NYSE:UIS).

Industry description

The industry, whose total market cap runs into trillions, makes hardware/software that allows data to be stored, retrieved, transmitted, and manipulated on computers. With the ever-increasing relevance of data, the information technology (IT) industry has gained momentous growth over the years, and continues to thrive on innovation. Some of the behemoths in the industry are International Business Machines Corporation, Accenture, and VMware, Inc.

Market Cap

The average market capitalization across the Information Technology Services Industry is 8.39B. The market cap for tickers in the group ranges from 100 to 207.9B. IBM holds the highest valuation in this group at 207.9B. The lowest valued company is ARSC at 100.

High and low price notable news

The average weekly price growth across all stocks in the Information Technology Services Industry was 0%. For the same Industry, the average monthly price growth was -6%, and the average quarterly price growth was -1%. VEEA experienced the highest price growth at 100%, while SGRX experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Information Technology Services Industry was 40%. For the same stocks of the Industry, the average monthly volume growth was 43% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 47
P/E Growth Rating: 64
Price Growth Rating: 60
SMR Rating: 73
Profit Risk Rating: 93
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
IT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a provider of information technology, research and consulting services

Industry InformationTechnologyServices

Industry
Miscellaneous Commercial Services
Address
56 Top Gallant Road
Phone
+1 203 964-0096
Employees
20244
Web
https://www.gartner.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
GE Aerospace (GE) stock declined -12% over the past 30 days, falling from around $333 to $293, amid profit-taking after record highs near $348. Over the past quarter, the stock is down -8%, reflecting post-earnings selloff despite strong Q4 2025 results with 20% revenue growth.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
NBR stock rose approximately +12% over the last 30 days, driven by positive momentum in the oil and gas drilling sector and strong Q4 earnings beat. Over the past quarter, the stock surged +58%, fueled by robust YTD performance, debt reduction efforts, and improved operational results in international drilling.
Patterson-UTI Energy, Inc. (PTEN) stands out as a leading provider of drilling and completion services to oil and natural gas exploration and production companies, primarily in the United States and select international markets. The company operates through three main segments: Drilling Services, which includes contract drilling rigs and directional drilling; Completion Services, encompassing hydraulic fracturing, wireline, and pumping; and Drilling Products, offering specialized drill bits globally, including in the Middle East.
As a provider of onshore drilling and completion services, Patterson-UTI Energy (PTEN) is gearing up for a key Q1 2026 earnings report against the backdrop of fluctuating oil prices and steady U.S. rig demand. The company's integrated approach across Drilling Services, Completion Services, and Drilling Products gives it a solid footing in North American shale plays. In my view, recent quarters like Q4 2025, where revenue exceeded estimates despite a net loss, highlight its resilience. This upcoming report will offer insights into activity levels, margin trends, and capital discipline amid supply growth and geopolitical tensions. With strong free cash flow and recent dividend increases, PTEN's focus on shareholders stands out, making this a critical gauge for the 2026 outlook in the cyclical oilfield services sector.
When geopolitical turmoil sends markets into chaos, most retail traders freeze — but Tickeron's Energy (OXY, EOG, DVN, FANG, APA, MTDR) AI Trading Agent is built to thrive in exactly these conditions. This 15-minute and 60-minute AI-powered robot has delivered a +76.22% annualized return with a 64.21% win rate and a Profit Factor of 2.70 — trading six of the most volatile and opportunity-rich energy tickers on the market.
The global energy sector is on fire — literally and figuratively. With crude oil prices swinging 20–30% in response to geopolitical flashpoints, OPEC+ production cuts, and escalating conflicts in Eastern Europe and the Middle East, traders who aren't using AI-powered tools are flying blind. Enter Tickeron's Energy (Oil & Gas – E&P) AI Trading Agent — a 60-minute signal robot built exclusively around five high-impact Exploration & Production tickers, now posting a staggering +49% Annualized Return and +1,251% 30-Day Annualized Return, with $14,703 in closed-trade P&L on a $30,000 simulated balance.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.